Something shifted in the White House’s relationship with cannabis policy last week, and it didn’t arrive with fanfare. Buried inside President Donald Trump’s Fiscal Year 2027 budget request, sent to Congress on Friday, was a quiet reversal of years of federal posturing: for the first time, Trump is asking lawmakers to keep the rider that shields state medical marijuana programs from Department of Justice interference.

That might not sound like a revolution. But for advocates who have watched this administration’s budget requests since 2017, the shift reads like a significant change of direction.

Every year of Trump’s first term, his budget proposals asked Congress to delete the medical cannabis protection entirely. Last year, same thing. Now, heading into FY2027, his administration is proposing to leave it in place.

The rider in question has been part of federal appropriations law since 2014. It prohibits the DOJ from spending any funds to interfere with states implementing their own medical marijuana laws, covering everything from cultivation to distribution to possession. The list of protected states runs nearly the full length of the country, from Alabama to Wyoming. Notably absent from the language is Nebraska, which does have a medical cannabis law on the books. The reason for that omission remains unexplained.

For California, which has operated one of the country’s oldest and most complex medical cannabis programs, the rider has always mattered in ways that go beyond symbolism. It creates a buffer between state-licensed operators, patients, and the long arm of federal prosecution. Without it, the DOJ would face no explicit appropriations-based restriction on targeting state-compliant medical programs.

Congress has never actually deleted the provision, regardless of what any president has asked. Even during Trump’s first term, when he requested its removal three times, lawmakers kept the rider in the final appropriations bills. Trump signed those bills into law, but each time he attached a signing statement suggesting his administration reserved the right to disregard the provision anyway, citing his constitutional duty to faithfully execute federal law. Those statements put the cannabis industry on edge. They signaled that the protection might be more fragile than it appeared on paper.

This time, the administration is not signaling that. It is asking for the rider to stay.

Joe Biden had consistently included the medical cannabis protection in his budget requests, keeping the rider intact as a matter of policy continuity. Barack Obama had sought to remove it, similar to Trump’s first-term approach. The new Trump position lands somewhere closer to Biden’s posture on this specific question, which is not a sentence anyone expected to write in the spring of 2026.

What hasn’t changed is the D.C. situation. The same budget proposal that now supports medical marijuana protections continues to block Washington, D.C. from legalizing recreational cannabis sales. That restriction has been embedded in appropriations language for years, preventing local D.C. officials from setting up a regulated commercial market even though residents voted to legalize possession and home cultivation back in 2014. The District exists in a strange legal gray zone because of it, where gifting cannabis is technically legal but taxed retail sales are not. The Trump FY2027 proposal keeps that wall standing.

For cannabis policy watchers, the two positions together tell a specific story. The administration appears willing to defend the patchwork of state medical programs that now covers most of the country, while drawing a hard line against any expansion toward recreational legalization at the federal level, and keeping D.C. in particular as a controlled example of what federal authority over local governance looks like.

For Humboldt County, where medical cannabis cultivation and small-farm legacy operations have always existed in complicated relationship with federal law, the rider’s proposed continuation is the kind of background protection that rarely makes headlines but shapes daily reality. Medical patients, licensed cultivators growing for medical markets, and dispensaries serving patients have all operated with the implicit understanding that the DOJ’s hands are, at least in appropriations terms, tied. That understanding would remain intact under the proposed budget.

The rider does not protect recreational programs. It never has. Lawmakers have never extended the appropriations protection to cover adult-use operations, even as 24 states, including California, have moved to full legalization. That gap is real and has always created a two-tier system where medical operations carry more federal insulation than recreational ones, even when the plant and the farm are identical.

Whether Congress will pass the FY2027 budget on time, in anything resembling its proposed form, is a separate question. Appropriations negotiations are rarely clean, and the budget request is a starting position, not a final document. But the fact that Trump’s administration put the medical cannabis rider in the proposal at all, rather than asking for its removal as it had done every prior year, gives advocates something they haven’t had from this White House before.

A budget request they don’t have to fight from the opening line.